메뉴 건너뛰기




Volumn 37, Issue 31, 2016, Pages 2455-2464

Antithrombotic therapy in heart failure patients with and without atrial fibrillation: Update and future challenges

Author keywords

Atrial fibrillation; Heart failure; Non Vitamin K antagonists oral anticoagulants; Vitamin K antagonists

Indexed keywords

ANTICOAGULANT AGENT; ANTIVITAMIN K; FIBRINOLYTIC AGENT;

EID: 85012905038     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehw213     Document Type: Article
Times cited : (27)

References (100)
  • 3
    • 84868523625 scopus 로고    scopus 로고
    • 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: An update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association
    • Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnloser SH, Hindricks G, Kirchhof P. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: An update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J 2012;33: 2719-2747.
    • (2012) Eur Heart J , vol.33 , pp. 2719-2747
    • Camm, A.J.1    Lip, G.Y.2    De Caterina, R.3    Savelieva, I.4    Atar, D.5    Hohnloser, S.H.6    Hindricks, G.7    Kirchhof, P.8
  • 4
    • 34347394385 scopus 로고    scopus 로고
    • Meta-analysis: Antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation
    • Hart RG, Pearce LA, Aguilar MI. Meta-analysis: Antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 2007; 146: 857-867.
    • (2007) Ann Intern Med , vol.146 , pp. 857-867
    • Hart, R.G.1    Pearce, L.A.2    Aguilar, M.I.3
  • 6
    • 84922255160 scopus 로고    scopus 로고
    • Heart failure and atrial fibrillation: From basic science to clinical practice
    • Ferreira JP, Santos M. Heart Failure and Atrial Fibrillation: From Basic Science to Clinical Practice. Int J Mol Sci 2015;16: 3133-3147.
    • (2015) Int J Mol Sci , vol.16 , pp. 3133-3147
    • Ferreira, J.P.1    Santos, M.2
  • 8
    • 0031686381 scopus 로고    scopus 로고
    • Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: A retrospective analysis of the SOLVD trials. Studies of Left Ventricular Dysfunction
    • Dries DL, Exner DV, Gersh BJ, Domanski MJ,Waclawiw MA, Stevenson LW. Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: A retrospective analysis of the SOLVD trials. Studies of Left Ventricular Dysfunction. J Am Coll Cardiol 1998;32: 695-703.
    • (1998) J Am Coll Cardiol , vol.32 , pp. 695-703
    • Dries, D.L.1    Exner, D.V.2    Gersh, B.J.3    Domanski, M.J.4    Waclawiw, M.A.5    Stevenson, L.W.6
  • 9
    • 0037456855 scopus 로고    scopus 로고
    • Atrial fibrillation in heart failure: Epidemiology, pathophysiology, and rationale for therapy
    • Maisel WH, Stevenson LW. Atrial fibrillation in heart failure: Epidemiology, pathophysiology, and rationale for therapy. Am J Cardiol 2003;91: 2d-8d.
    • (2003) Am J Cardiol , vol.91 , pp. 2d-8d
    • Maisel, W.H.1    Stevenson, L.W.2
  • 10
    • 0027998462 scopus 로고
    • Randomised trial of low-dose amiodarone in severe congestive heart failure. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA)
    • Doval HC, Nul DR, Grancelli HO, Perrone SV, Bortman GR, Curiel R. Randomised trial of low-dose amiodarone in severe congestive heart failure. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA). Lancet 1994;344: 493-498.
    • (1994) Lancet , vol.344 , pp. 493-498
    • Doval, H.C.1    Nul, D.R.2    Grancelli, H.O.3    Perrone, S.V.4    Bortman, G.R.5    Curiel, R.6
  • 11
    • 0027229344 scopus 로고
    • The influence of atrial fibrillation on prognosis in mild to moderate heart failure. The VHeFT Studies. The V-HeFT VA Cooperative Studies Group
    • Carson PE, Johnson GR, Dunkman WB, Fletcher RD, Farrell L, Cohn JN. The influence of atrial fibrillation on prognosis in mild to moderate heart failure. The VHeFT Studies. The V-HeFT VA Cooperative Studies Group. Circulation 1993;87(6 Suppl): Vi102-Vi110.
    • (1993) Circulation , vol.87 , Issue.6 , pp. Vi102-Vi110
    • Carson, P.E.1    Johnson, G.R.2    Dunkman, W.B.3    Fletcher, R.D.4    Farrell, L.5    Cohn, J.N.6
  • 12
    • 0032497913 scopus 로고    scopus 로고
    • Spontaneous conversion and maintenance of sinus rhythm by amiodarone in patients with heart failure and atrial fibrillation: Observations from the veterans affairs congestive heart failure survival trial of antiarrhythmic therapy (CHF-STAT
    • Deedwania PC, Singh BN, Ellenbogen K, Fisher S, Fletcher R, Singh SN. Spontaneous conversion and maintenance of sinus rhythm by amiodarone in patients with heart failure and atrial fibrillation: Observations from the veterans affairs congestive heart failure survival trial of antiarrhythmic therapy (CHF-STAT). The Department of Veterans Affairs CHF-STAT Investigators. Circulation 1998;98: 2574-2579.
    • (1998) Circulation , vol.98 , pp. 2574-2579
    • Deedwania, P.C.1    Singh, B.N.2    Ellenbogen, K.3    Fisher, S.4    Fletcher, R.5    Singh, S.N.6
  • 14
    • 0023694997 scopus 로고
    • Effects of enalapril on mortality in severe congestive heart failure: Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS
    • Swedberg K, Kjekshus J. Effects of enalapril on mortality in severe congestive heart failure: Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). Am J Cardiol 1988;62: 60A-66A.
    • (1988) Am J Cardiol , vol.62 , pp. 60A-66A
    • Swedberg, K.1    Kjekshus, J.2
  • 16
    • 84947866649 scopus 로고    scopus 로고
    • Rationale and design of a randomized, double-blind, event-driven, multicentre study comparing the efficacy and safety of oral rivaroxaban with placebo for reducing the risk of death, myocardial infarction or stroke in subjects with heart failure and significant coronary artery disease following an exacerbation of heart failure: The COMMANDER HF trial
    • Zannad F, Greenberg B, Cleland JG, Gheorghiade M, van Veldhuisen DJ, Mehra MR, Anker SD, Byra WM, Fu M, Mills RM. Rationale and design of a randomized, double-blind, event-driven, multicentre study comparing the efficacy and safety of oral rivaroxaban with placebo for reducing the risk of death, myocardial infarction or stroke in subjects with heart failure and significant coronary artery disease following an exacerbation of heart failure: The COMMANDER HF trial. Eur J Heart Fail 2015;17: 735-742.
    • (2015) Eur J Heart Fail , vol.17 , pp. 735-742
    • Zannad, F.1    Greenberg, B.2    Cleland, J.G.3    Gheorghiade, M.4    Van Veldhuisen, D.J.5    Mehra, M.R.6    Anker, S.D.7    Byra, W.M.8    Fu, M.9    Mills, R.M.10
  • 17
    • 77950481355 scopus 로고    scopus 로고
    • Atrial fibrillation in heart failure: A comprehensive review
    • Deedwania PC, Lardizabal JA. Atrial fibrillation in heart failure: A comprehensive review. Am J Med 2010;123: 198-204.
    • (2010) Am J Med , vol.123 , pp. 198-204
    • Deedwania, P.C.1    Lardizabal, J.A.2
  • 19
    • 84864477617 scopus 로고    scopus 로고
    • Developed in collaboration with the Heart Failure Association (HFA) of the ESC
    • Bax JJ Baumgartner H Ceconi C Dean V Deaton C Fagard R Funck-Brentano C Hasdai D Hoes A Kirchhof P Knuuti J Kolh P McDonagh T Moulin C Popescu BA Reiner Z Sechtem U Sirnes PA Tendera M Torbicki A Vahanian A Windecker S McDonagh T Sechtem U Bonet LA Avraamides P Ben Lamin HA Brignole M Coca A Cowburn P Dargie H Elliott P Flachskampf FA Guida GF Hardman S Iung B Merkely B Mueller C Nanas JN NielsenOW Orn S Parissis JT Ponikowski P. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology
    • McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Böhm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, Jaarsma T, Køber L, Lip GY, Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, Rønnevik PK, Rutten FH, Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zannad F, Zeiher A; Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology, Bax JJ, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Kirchhof P, Knuuti J, Kolh P, McDonagh T, Moulin C, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Torbicki A, Vahanian A, Windecker S, McDonagh T, Sechtem U, Bonet LA, Avraamides P, Ben Lamin HA, Brignole M, Coca A, Cowburn P, Dargie H, Elliott P, Flachskampf FA, Guida GF, Hardman S, Iung B, Merkely B, Mueller C, Nanas JN, NielsenOW, Orn S, Parissis JT, Ponikowski P. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 2012;14: 803-869.
    • (2012) Eur J Heart Fail , vol.14 , pp. 803-869
    • McMurray, J.J.1    Adamopoulos, S.2    Anker, S.D.3    Auricchio, A.4    Böhm, M.5    Dickstein, K.6    Falk, V.7    Filippatos, G.8    Fonseca, C.9    Gomez-Sanchez, M.A.10    Jaarsma, T.11    Køber, L.12    Lip, G.Y.13    Maggioni, A.P.14    Parkhomenko, A.15    Pieske, B.M.16    Popescu, B.A.17    Rønnevik, P.K.18    Rutten, F.H.19    Schwitter, J.20    more..
  • 20
    • 84898024964 scopus 로고    scopus 로고
    • Global burden of atrial fibrillation in developed and developing nations
    • Chugh SS, Roth GA, Gillum RF, Mensah GA. Global burden of atrial fibrillation in developed and developing nations. Glob Heart 2014;9: 113-119.
    • (2014) Glob Heart , vol.9 , pp. 113-119
    • Chugh, S.S.1    Roth, G.A.2    Gillum, R.F.3    Mensah, G.A.4
  • 22
    • 84940426249 scopus 로고    scopus 로고
    • Residual risk of stroke and death in anticoagulated patients according to the type of atrial fibrillation: AMADEUS trial
    • Senoo K, Lip GY, Lane DA, Buller HR, Kotecha D. Residual risk of stroke and death in anticoagulated patients according to the type of atrial fibrillation: AMADEUS trial. Stroke 2015;46: 2523-2528.
    • (2015) Stroke , vol.46 , pp. 2523-2528
    • Senoo, K.1    Lip, G.Y.2    Lane, D.A.3    Buller, H.R.4    Kotecha, D.5
  • 24
    • 84962009900 scopus 로고    scopus 로고
    • Document Reviewers: Gorenek B, Lane D, Boriani G, Linde C, Hindricks G, Tsutsui H, Homma S, Brownstein S, Nielsen JC, Lainscak M, Crespo-Leiro M, Piepoli M, Seferovic P, Savelieva I. European Heart Rhythm Association/Heart Failure Association joint consensus document on arrhythmias in heart failure, endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society
    • Lip GY, Heinzel FR, Gaita F, Juanatey JR, Le Heuzey JY, Potpara T, Svendsen JH, Vos MA, Anker SD, Coats AJ, Haverkamp W, Manolis AS, Chung MK, Sanders P, Pieske B; Document Reviewers: Gorenek B, Lane D, Boriani G, Linde C, Hindricks G, Tsutsui H, Homma S, Brownstein S, Nielsen JC, Lainscak M, Crespo-Leiro M, Piepoli M, Seferovic P, Savelieva I. European Heart Rhythm Association/Heart Failure Association joint consensus document on arrhythmias in heart failure, endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society. Europace 2016;18: 12-36.
    • (2016) Europace , vol.18 , pp. 12-36
    • Lip, G.Y.1    Heinzel, F.R.2    Gaita, F.3    Juanatey, J.R.4    Le Heuzey, J.Y.5    Potpara, T.6    Svendsen, J.H.7    Vos, M.A.8    Anker, S.D.9    Coats, A.J.10    Haverkamp, W.11    Manolis, A.S.12    Chung, M.K.13    Sanders, P.14    Pieske, B.15
  • 33
    • 84942409774 scopus 로고    scopus 로고
    • Randomized trial of atrial arrhythmia monitoring to guide anticoagulation in patients with implanted defibrillator and cardiac resynchronization devices
    • Martin DT, Bersohn MM, Waldo AL, Wathen MS, Choucair WK, Lip GY, Ip J, Holcomb R, Akar JG, Halperin JL. Randomized trial of atrial arrhythmia monitoring to guide anticoagulation in patients with implanted defibrillator and cardiac resynchronization devices. Eur Heart J 2015;36: 1660-1668.
    • (2015) Eur Heart J , vol.36 , pp. 1660-1668
    • Martin, D.T.1    Bersohn, M.M.2    Waldo, A.L.3    Wathen, M.S.4    Choucair, W.K.5    Lip, G.Y.6    Ip, J.7    Holcomb, R.8    Akar, J.G.9    Halperin, J.L.10
  • 34
    • 84903434770 scopus 로고    scopus 로고
    • Heart-rhythm monitoring for evaluation of cryptogenic stroke
    • Kamel H. Heart-rhythm monitoring for evaluation of cryptogenic stroke. N Engl J Med 2014;370: 2532-2533.
    • (2014) N Engl J Med , vol.370 , pp. 2532-2533
    • Kamel, H.1
  • 37
    • 0035854054 scopus 로고    scopus 로고
    • Validation of clinical classification schemes for predicting stroke: Results from the National Registry of Atrial Fibrillation
    • Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ. Validation of clinical classification schemes for predicting stroke: Results from the National Registry of Atrial Fibrillation. JAMA 2001;285: 2864-2870.
    • (2001) JAMA , vol.285 , pp. 2864-2870
    • Gage, B.F.1    Waterman, A.D.2    Shannon, W.3    Boechler, M.4    Rich, M.W.5    Radford, M.J.6
  • 38
    • 76749163232 scopus 로고    scopus 로고
    • Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: The euro heart survey on atrial fibrillation
    • Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: The euro heart survey on atrial fibrillation. Chest 2010; 137: 263-272.
    • (2010) Chest , vol.137 , pp. 263-272
    • Lip, G.Y.1    Nieuwlaat, R.2    Pisters, R.3    Lane, D.A.4    Crijns, H.J.5
  • 39
    • 77954392300 scopus 로고    scopus 로고
    • The CHADS2 score for stroke risk stratification in atrial fibrillation-friend or foe?
    • Karthikeyan G, Eikelboom JW. The CHADS2 score for stroke risk stratification in atrial fibrillation-friend or foe? Thromb Haemost 2010;104: 45-48.
    • (2010) Thromb Haemost , vol.104 , pp. 45-48
    • Karthikeyan, G.1    Eikelboom, J.W.2
  • 41
    • 84945978079 scopus 로고    scopus 로고
    • Comparative performance of ATRIA, CHADS2, and CHA2DS2-VASc risk scores predicting stroke in patients with atrial fibrillation: Results from a national primary care database
    • van den Ham HA, Klungel OH, Singer DE, Leufkens HG, van Staa TP. Comparative Performance of ATRIA, CHADS2, and CHA2DS2-VASc Risk Scores Predicting Stroke in Patients With Atrial Fibrillation: Results From a National Primary Care Database. J Am Coll Cardiol 2015;66: 1851-1859.
    • (2015) J Am Coll Cardiol , vol.66 , pp. 1851-1859
    • Van Den Ham, H.A.1    Klungel, O.H.2    Singer, D.E.3    Leufkens, H.G.4    Van Staa, T.P.5
  • 42
    • 84947779709 scopus 로고    scopus 로고
    • Comparison between CHA2DS2-VASc and the new R2CHADS2 and ATRIA scores at predicting thromboembolic event in non-anticoagulated and anticoagulated patients with non-valvular atrial fibrillation
    • Abumuaileq RR, Abu-Assi E, Lopez-Lopez A, Raposeiras-Roubin S, Rodriguez- Manero M, Martinez-Sande L. Comparison between CHA2DS2-VASc and the new R2CHADS2 and ATRIA scores at predicting thromboembolic event in non-anticoagulated and anticoagulated patients with non-valvular atrial fibrillation. BMC Cardiovasc Disord 2015;15: 156.
    • (2015) BMC Cardiovasc Disord , vol.15 , pp. 156
    • Abumuaileq, R.R.1    Abu-Assi, E.2    Lopez-Lopez, A.3    Raposeiras-Roubin, S.4    Rodriguez-Manero, M.5    Martinez-Sande, L.6
  • 43
    • 84907969698 scopus 로고    scopus 로고
    • Using the CHA2DS2-VASc score for refining stroke risk stratification in 'low-risk' Asian patients with atrial fibrillation
    • Chao TF, Liu CJ, Wang KL, Lin YJ, Chang SL, Lo LW. Using the CHA2DS2-VASc score for refining stroke risk stratification in 'low-risk' Asian patients with atrial fibrillation. J Am Coll Cardiol 2014;64: 1658-1665.
    • (2014) J Am Coll Cardiol , vol.64 , pp. 1658-1665
    • Chao, T.F.1    Liu, C.J.2    Wang, K.L.3    Lin, Y.J.4    Chang, S.L.5    Lo, L.W.6
  • 44
    • 84941625442 scopus 로고    scopus 로고
    • Assessment of the CHA2DS2-VASc score in predicting ischemic stroke, thromboembolism, and death in patients with heart failure with and without atrial fibrillation
    • Melgaard L, Gorst-Rasmussen A, Lane DA, Rasmussen LH, Larsen TB, Lip GY. Assessment of the CHA2DS2-VASc Score in Predicting Ischemic Stroke, Thromboembolism, and Death in Patients With Heart Failure With and Without Atrial Fibrillation. JAMA 2015;314: 1030-1038.
    • (2015) JAMA , vol.314 , pp. 1030-1038
    • Melgaard, L.1    Gorst-Rasmussen, A.2    Lane, D.A.3    Rasmussen, L.H.4    Larsen, T.B.5    Lip, G.Y.6
  • 45
    • 34548455445 scopus 로고    scopus 로고
    • Independent predictors of stroke in patients with atrial fibrillation: A systematic review
    • Melgaard L. Independent predictors of stroke in patients with atrial fibrillation: A systematic review. Neurology 2007;69: 546-554.
    • (2007) Neurology , vol.69 , pp. 546-554
    • Melgaard, L.1
  • 46
    • 84929297023 scopus 로고    scopus 로고
    • Relationship between degree of left ventricular dysfunction, symptom status, and risk of embolic events in patients with atrial fibrillation and heart failure
    • Sandhu RK, Hohnloser SH, Pfeffer MA, Yuan F, Hart RG, Yusuf S, Connolly SJ, McAlister FA, Healey JS. Relationship between degree of left ventricular dysfunction, symptom status, and risk of embolic events in patients with atrial fibrillation and heart failure. Stroke 2015;46: 667-672.
    • (2015) Stroke , vol.46 , pp. 667-672
    • Sandhu, R.K.1    Hohnloser, S.H.2    Pfeffer, M.A.3    Yuan, F.4    Hart, R.G.5    Yusuf, S.6    Connolly, S.J.7    McAlister, F.A.8    Healey, J.S.9
  • 48
    • 80054712170 scopus 로고    scopus 로고
    • Comparison of mortality and morbidity in patients with atrial fibrillation and heart failure with preserved versus decreased left ventricular ejection fraction
    • Badheka AO, Rathod A, Kizilbash MA, Bhardwaj A, Ali O, Afonso L, Jacob S. Comparison of mortality and morbidity in patients with atrial fibrillation and heart failure with preserved versus decreased left ventricular ejection fraction. Am J Cardiol 2011;108: 1283-1288.
    • (2011) Am J Cardiol , vol.108 , pp. 1283-1288
    • Badheka, A.O.1    Rathod, A.2    Kizilbash, M.A.3    Bhardwaj, A.4    Ali, O.5    Afonso, L.6    Jacob, S.7
  • 49
    • 33646254610 scopus 로고    scopus 로고
    • Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: Results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) program
    • Olsson LG, Swedberg K, Ducharme A, Granger CB, Michelson EL, McMurray JJ, Puu M, Yusuf S, Pfeffer MA. Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: Results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) program. J Am Coll Cardiol 2006;47: 1997-2004.
    • (2006) J Am Coll Cardiol , vol.47 , pp. 1997-2004
    • Olsson, L.G.1    Swedberg, K.2    Ducharme, A.3    Granger, C.B.4    Michelson, E.L.5    McMurray, J.J.6    Puu, M.7    Yusuf, S.8    Pfeffer, M.A.9
  • 50
    • 34547693119 scopus 로고    scopus 로고
    • Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): A randomised controlled trial
    • Mant J, Hobbs FD, Fletcher K, Roalfe A, Fitzmaurice D, Lip GY, Murray E.Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): A randomised controlled trial. Lancet 2007;370: 493-503.
    • (2007) Lancet , vol.370 , pp. 493-503
    • Mant, J.1    Hobbs, F.D.2    Fletcher, K.3    Roalfe, A.4    Fitzmaurice, D.5    Lip, G.Y.6    Murray, E.7
  • 51
    • 78649342646 scopus 로고    scopus 로고
    • Patient characteristics associated with oral anticoagulation control: Results of the Veterans AffaiRs Study to Improve Anticoagulation (VARIA
    • Rose AJ, Hylek EM, Ozonoff A, Ash AS, Reisman JI, Berlowitz DR. Patient characteristics associated with oral anticoagulation control: Results of the Veterans AffaiRs Study to Improve Anticoagulation (VARIA). J Thromb Haemost 2010;8: 2182-2191.
    • (2010) J Thromb Haemost , vol.8 , pp. 2182-2191
    • Rose, A.J.1    Hylek, E.M.2    Ozonoff, A.3    Ash, A.S.4    Reisman, J.I.5    Berlowitz, D.R.6
  • 52
    • 78650878679 scopus 로고    scopus 로고
    • Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation: The HAS-BLED (Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly, Drugs/Alcohol Concomitantly) score
    • Lip GY, Frison L, Halperin JL, Lane DA. Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation: The HAS-BLED (Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly, Drugs/Alcohol Concomitantly) score. J Am Coll Cardiol 2011;57: 173-180.
    • (2011) J Am Coll Cardiol , vol.57 , pp. 173-180
    • Lip, G.Y.1    Frison, L.2    Halperin, J.L.3    Lane, D.A.4
  • 53
    • 17044428901 scopus 로고    scopus 로고
    • Factors affecting bleeding risk during anticoagulant therapy in patients with atrial fibrillation: Observations from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study
    • DiMarco JP, Flaker G, Waldo AL, Corley SD, Greene HL, Safford RE. Factors affecting bleeding risk during anticoagulant therapy in patients with atrial fibrillation: Observations from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. Am Heart J 2005;149: 650-656.
    • (2005) Am Heart J , vol.149 , pp. 650-656
    • DiMarco, J.P.1    Flaker, G.2    Waldo, A.L.3    Corley, S.D.4    Greene, H.L.5    Safford, R.E.6
  • 56
    • 80052094564 scopus 로고    scopus 로고
    • A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study
    • Fang MC, Go AS, Chang Y, Borowsky LH, Pomernacki NK, Udaltsova N, Singer DE. A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study. J Am Coll Cardiol 2011;58: 395-401.
    • (2011) J Am Coll Cardiol , vol.58 , pp. 395-401
    • Fang, M.C.1    Go, A.S.2    Chang, Y.3    Borowsky, L.H.4    Pomernacki, N.K.5    Udaltsova, N.6    Singer, D.E.7
  • 57
    • 33344461585 scopus 로고    scopus 로고
    • Clinical classification schemes for predicting hemorrhage: Results from the National Registry of Atrial Fibrillation (NRAF
    • Gage BF, Yan Y, Milligan PE, Waterman AD, Culverhouse R, Rich MW. Clinical classification schemes for predicting hemorrhage: Results from the National Registry of Atrial Fibrillation (NRAF). Am Heart J 2006;151: 713-719.
    • (2006) Am Heart J , vol.151 , pp. 713-719
    • Gage, B.F.1    Yan, Y.2    Milligan, P.E.3    Waterman, A.D.4    Culverhouse, R.5    Rich, M.W.6
  • 58
    • 46749145855 scopus 로고    scopus 로고
    • Predictive variables for major bleeding events in patients presenting with documented acute venous thromboembolism. Findings from the RIETE Registry
    • Ruiz-Gimenez N, Suarez C, Gonzalez R, Nieto JA, Todoli JA, Samperiz AL. Predictive variables for major bleeding events in patients presenting with documented acute venous thromboembolism. Findings from the RIETE Registry. Thromb Haemost 2008;100: 26-31.
    • (2008) Thromb Haemost , vol.100 , pp. 26-31
    • Ruiz-Gimenez, N.1    Suarez, C.2    Gonzalez, R.3    Nieto, J.A.4    Todoli, J.A.5    Samperiz, A.L.6
  • 59
    • 77955872745 scopus 로고    scopus 로고
    • A novel userfriendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: The Euro Heart Survey
    • Pisters R, Lane DA, Nieuwlaat R, de Vos CB, Crijns HJ, Lip GY. A novel userfriendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: The Euro Heart Survey. Chest 2010;138: 1093-1100.
    • (2010) Chest , vol.138 , pp. 1093-1100
    • Pisters, R.1    Lane, D.A.2    Nieuwlaat, R.3    De Vos, C.B.4    Crijns, H.J.5    Lip, G.Y.6
  • 60
    • 80055079237 scopus 로고    scopus 로고
    • Risk of bleeding with oral anticoagulants: An updated systematic review and performance analysis of clinical prediction rules
    • Loewen P, Dahri K. Risk of bleeding with oral anticoagulants: An updated systematic review and performance analysis of clinical prediction rules. Ann Hematol 2011;90: 1191-1200.
    • (2011) Ann Hematol , vol.90 , pp. 1191-1200
    • Loewen, P.1    Dahri, K.2
  • 61
    • 84865292043 scopus 로고    scopus 로고
    • Performance of the HEMORR( 2)HAGES, ATRIA, and HAS-BLED bleeding risk-prediction scores in patients with atrial fibrillation undergoing anticoagulation: The AMADEUS (evaluating the use of SR34006 compared to warfarin or acenocoumarol in patients with atrial fibrillation) study
    • Apostolakis S, Lane DA, Guo Y, Buller H, Lip GY. Performance of the HEMORR( 2)HAGES, ATRIA, and HAS-BLED bleeding risk-prediction scores in patients with atrial fibrillation undergoing anticoagulation: The AMADEUS (evaluating the use of SR34006 compared to warfarin or acenocoumarol in patients with atrial fibrillation) study. J Am Coll Cardiol 2012;60: 861-867.
    • (2012) J Am Coll Cardiol , vol.60 , pp. 861-867
    • Apostolakis, S.1    Lane, D.A.2    Guo, Y.3    Buller, H.4    Lip, G.Y.5
  • 62
    • 84883747848 scopus 로고    scopus 로고
    • Clinical performance of bleeding risk scores for predicting major and clinically relevant non-major bleeding events in patients receiving warfarin
    • Burgess S, Crown N, Louzada ML, Dresser G, Kim RB, Lazo-Langner A. Clinical performance of bleeding risk scores for predicting major and clinically relevant non-major bleeding events in patients receiving warfarin. J Thromb Haemost 2013;11: 1647-1654.
    • (2013) J Thromb Haemost , vol.11 , pp. 1647-1654
    • Burgess, S.1    Crown, N.2    Louzada, M.L.3    Dresser, G.4    Kim, R.B.5    Lazo-Langner, A.6
  • 63
    • 84901924134 scopus 로고    scopus 로고
    • Systematic review and network meta-analysis comparing antithrombotic agents for the prevention of stroke and major bleeding in patients with atrial fibrillation
    • Cameron C, Coyle D, Richter T, Kelly S, Gauthier K, Steiner S. Systematic review and network meta-analysis comparing antithrombotic agents for the prevention of stroke and major bleeding in patients with atrial fibrillation. BMJ Open 2014; 4: E004301.
    • (2014) BMJ Open , vol.4 , pp. e004301
    • Cameron, C.1    Coyle, D.2    Richter, T.3    Kelly, S.4    Gauthier, K.5    Steiner, S.6
  • 64
    • 84937970837 scopus 로고    scopus 로고
    • Bleeding risk, management and outcome in patients receiving non-VKA oral anticoagulants (NOACs
    • Werth S, Breslin T, NiAinle F, Beyer-Westendorf J. Bleeding risk, management and outcome in patients receiving non-VKA oral anticoagulants (NOACs). Am J Cardiovasc Drugs 2015;15: 235-242.
    • (2015) Am J Cardiovasc Drugs , vol.15 , pp. 235-242
    • Werth, S.1    Breslin, T.2    NiAinle, F.3    Beyer-Westendorf, J.4
  • 65
    • 0032144231 scopus 로고    scopus 로고
    • Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin
    • Beyth RJ, Quinn LM, Landefeld CS. Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin. Am J Med 1998; 105: 91-99.
    • (1998) Am J Med , vol.105 , pp. 91-99
    • Beyth, R.J.1    Quinn, L.M.2    Landefeld, C.S.3
  • 66
    • 0031470151 scopus 로고    scopus 로고
    • Major haemorrhagic complications during oral anticoagulant therapy in a Danish populationbased cohort
    • Steffensen FH, Kristensen K, Ejlersen E, Dahlerup JF, Sorensen HT. Major haemorrhagic complications during oral anticoagulant therapy in a Danish populationbased cohort. J Intern Med 1997;242: 497-503.
    • (1997) J Intern Med , vol.242 , pp. 497-503
    • Steffensen, F.H.1    Kristensen, K.2    Ejlersen, E.3    Dahlerup, J.F.4    Sorensen, H.T.5
  • 68
    • 41349089568 scopus 로고    scopus 로고
    • Management of atrial fibrillation in patients with heart failure
    • Efremidis M, Pappas L, Sideris A, Filippatos G. Management of atrial fibrillation in patients with heart failure. J Card Fail 2008;14: 232-237.
    • (2008) J Card Fail , vol.14 , pp. 232-237
    • Efremidis, M.1    Pappas, L.2    Sideris, A.3    Filippatos, G.4
  • 69
    • 84901375349 scopus 로고    scopus 로고
    • Dabigatran, rivaroxaban, or apixaban versus warfarin in patients with nonvalvular atrial fibrillation: A systematic eeview and meta-analysis of subgroups
    • Gomez-Outes A, Terleira-Fernandez AI, Calvo-Rojas G, Suarez-Gea ML, Vargas- Castrillon E. Dabigatran, rivaroxaban, or apixaban versus warfarin in patients with nonvalvular atrial fibrillation: A systematic eeview and meta-analysis of subgroups. Thrombosis 2013;2013: 640723.
    • (2013) Thrombosis , vol.2013 , pp. 640723
    • Gomez-Outes, A.1    Terleira-Fernandez, A.I.2    Calvo-Rojas, G.3    Suarez-Gea, M.L.4    Vargas-Castrillon, E.5
  • 70
    • 84869501537 scopus 로고    scopus 로고
    • Outcomes associated with warfarin use in older patients with heart failure and atrial fibrillation and a cardiovascular implantable electronic device: Findings from the ADHERE registry linked to Medicare claims
    • Hess PL, Greiner MA, Fonarow GC, KlaskalaW, Mills RM, Setoguchi S. Outcomes associated with warfarin use in older patients with heart failure and atrial fibrillation and a cardiovascular implantable electronic device: Findings from the ADHERE registry linked to Medicare claims. Clin Cardiol 2012;35: 649-657.
    • (2012) Clin Cardiol , vol.35 , pp. 649-657
    • Hess, P.L.1    Greiner, M.A.2    Fonarow, G.C.3    KlaskalaW Mills, R.M.4    Setoguchi, S.5
  • 71
  • 73
    • 84933586065 scopus 로고    scopus 로고
    • Efficacy and safety of edoxaban compared with warfarin in patients with atrial fibrillation and heart failure: Insights from Engage-AF TIMI
    • Abstract 12680
    • Magnani G, Giugliano RP, Ruff CT, Murphy SA, Nordio F, Rutman H. Efficacy and safety of edoxaban compared with warfarin in patients with atrial fibrillation and heart failure: Insights from Engage-AF TIMI 48. Circulation 2014; Abstract 12680.
    • (2014) Circulation , vol.48
    • Magnani, G.1    Giugliano, R.P.2    Ruff, C.T.3    Murphy, S.A.4    Nordio, F.5    Rutman, H.6
  • 79
    • 84871481386 scopus 로고    scopus 로고
    • Dabigatran compared with warfarin in patients with atrial fibrillation and symptomatic heart failure: A subgroup analysis of the RE-LY trial
    • Abstract 10956
    • Ferreira J, Ezekowitz MD, Connolly SJ, Reilly PA, Clemens A, Brueckmann M. Dabigatran compared with warfarin in patients with atrial fibrillation and symptomatic heart failure: A subgroup analysis of the RE-LY trial. Circulation 2011;Abstract 10956.
    • (2011) Circulation
    • Ferreira, J.1    Ezekowitz, M.D.2    Connolly, S.J.3    Reilly, P.A.4    Clemens, A.5    Brueckmann, M.6
  • 80
    • 84955215646 scopus 로고    scopus 로고
    • Non-Vitamin K antagonist oral anticoagulants (NOACs) in patients with concomitant atrial fibrillation and heart failure: A systemic review and meta-analysis of randomized trials
    • Xiong Q, Lau YC, Senoo K, Lane DA, Hong K, Lip GY. Non-vitamin K antagonist oral anticoagulants (NOACs) in patients with concomitant atrial fibrillation and heart failure: A systemic review and meta-analysis of randomized trials. Eur J Heart Fail 2015;17: 1192-1200.
    • (2015) Eur J Heart Fail , vol.17 , pp. 1192-1200
    • Xiong, Q.1    Lau, Y.C.2    Senoo, K.3    Lane, D.A.4    Hong, K.5    Lip, G.Y.6
  • 81
    • 4444256649 scopus 로고    scopus 로고
    • Quantifying the heart failure epidemic: Prevalence, incidence rate, lifetime risk and prognosis of heart failure The Rotterdam Study
    • Bleumink GS, Knetsch AM, Sturkenboom MC, Straus SM, Hofman A, Deckers JW. Quantifying the heart failure epidemic: Prevalence, incidence rate, lifetime risk and prognosis of heart failure The Rotterdam Study. Eur Heart J 2004;25: 1614-1619.
    • (2004) Eur Heart J , vol.25 , pp. 1614-1619
    • Bleumink, G.S.1    Knetsch, A.M.2    Sturkenboom, M.C.3    Straus, S.M.4    Hofman, A.5    Deckers, J.W.6
  • 82
    • 84896109810 scopus 로고    scopus 로고
    • Incidence, determinants, and prognostic significance of hyperkalemia and worsening renal function in patients with heart failure receiving the mineralocorticoid receptor antagonist eplerenone or placebo in addition to optimal medical therapy: Results from the Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure (EMPHASIS-HF
    • Rossignol P, Dobre D, McMurray JJ, Swedberg K, Krum H, van Veldhuisen DJ, Shi H, Messig M, Vincent J, Girerd N, Bakris G, Pitt B, Zannad F. Incidence, determinants, and prognostic significance of hyperkalemia and worsening renal function in patients with heart failure receiving the mineralocorticoid receptor antagonist eplerenone or placebo in addition to optimal medical therapy: Results from the Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure (EMPHASIS-HF). Circ Heart Fail 2014;7: 51-58.
    • (2014) Circ Heart Fail , vol.7 , pp. 51-58
    • Rossignol, P.1    Dobre, D.2    McMurray, J.J.3    Swedberg, K.4    Krum, H.5    Van Veldhuisen, D.J.6    Shi, H.7    Messig, M.8    Vincent, J.9    Girerd, N.10    Bakris, G.11    Pitt, B.12    Zannad, F.13
  • 83
    • 68349151861 scopus 로고    scopus 로고
    • Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: A randomised non-inferiority trial
    • Holmes DR, Reddy VY, Turi ZG, Doshi SK, Sievert H, Buchbinder M, Mullin CM, Sick P. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: A randomised non-inferiority trial. Lancet 2009;374: 534-542.
    • (2009) Lancet , vol.374 , pp. 534-542
    • Holmes, D.R.1    Reddy, V.Y.2    Turi, Z.G.3    Doshi, S.K.4    Sievert, H.5    Buchbinder, M.6    Mullin, C.M.7    Sick, P.8
  • 84
    • 84874001138 scopus 로고    scopus 로고
    • Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-Year Follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients with Atrial Fibrillation) Trial
    • Reddy VY, Doshi SK, Sievert H, Buchbinder M, Neuzil P, Huber K. Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-Year Follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients with Atrial Fibrillation) Trial. Circulation 2013;127: 720-729.
    • (2013) Circulation , vol.127 , pp. 720-729
    • Reddy, V.Y.1    Doshi, S.K.2    Sievert, H.3    Buchbinder, M.4    Neuzil, P.5    Huber, K.6
  • 85
    • 79751531253 scopus 로고    scopus 로고
    • Safety of percutaneous left atrial appendage closure: Results from theWatchman Left Atrial Appendage System for Embolic Protection in Patients with AF (PROTECT AF) clinical trial and the Continued Access Registry
    • Reddy VY, Holmes D, Doshi SK, Neuzil P, Kar S. Safety of percutaneous left atrial appendage closure: Results from theWatchman Left Atrial Appendage System for Embolic Protection in Patients with AF (PROTECT AF) clinical trial and the Continued Access Registry. Circulation 2011;123: 417-424.
    • (2011) Circulation , vol.123 , pp. 417-424
    • Reddy, V.Y.1    Holmes, D.2    Doshi, S.K.3    Neuzil, P.4    Kar, S.5
  • 86
    • 84903828960 scopus 로고    scopus 로고
    • Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: The PREVAIL trial
    • Holmes DR Jr, Kar S, Price MJ, Whisenant B, Sievert H, Doshi SK, Huber K, Reddy VY. Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: The PREVAIL trial. J Am Coll Cardiol 2014;64: 1-12.
    • (2014) J Am Coll Cardiol , vol.64 , pp. 1-12
    • Holmes, D.R.1    Kar, S.2    Price, M.J.3    Whisenant, B.4    Sievert, H.5    Doshi, S.K.6    Huber, K.7    Reddy, V.Y.8
  • 87
    • 84911388134 scopus 로고    scopus 로고
    • Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: A randomized clinical trial
    • Reddy VY, Sievert H, Halperin J, Doshi SK, Buchbinder M, Neuzil P. Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: A randomized clinical trial. JAMA 2014;312: 1988-1998.
    • (2014) JAMA , vol.312 , pp. 1988-1998
    • Reddy, V.Y.1    Sievert, H.2    Halperin, J.3    Doshi, S.K.4    Buchbinder, M.5    Neuzil, P.6
  • 88
    • 84931026720 scopus 로고    scopus 로고
    • Left atrial appendage closure as an alternative to warfarin for stroke prevention in atrial fibrillation: A patient-level meta-analysis
    • Holmes DR Jr, Doshi SK, Kar S, Price MJ, Sanchez JM, Sievert H. Left atrial appendage closure as an alternative to warfarin for stroke prevention in atrial fibrillation: A patient-level meta-analysis. J Am Coll Cardiol 2015;65: 2614-2623.
    • (2015) J Am Coll Cardiol , vol.65 , pp. 2614-2623
    • Holmes, D.R.1    Doshi, S.K.2    Kar, S.3    Price, M.J.4    Sanchez, J.M.5    Sievert, H.6
  • 89
    • 33144465561 scopus 로고    scopus 로고
    • Warfarin versus aspirin in patients with reduced cardiac ejection fraction (WARCEF): Rationale, objectives, and design
    • Pullicino P, Thompson JL, Barton B, Levin B, Graham S, Freudenberger RS. Warfarin versus aspirin in patients with reduced cardiac ejection fraction (WARCEF): Rationale, objectives, and design. J Card Fail 2006;12: 39-46.
    • (2006) J Card Fail , vol.12 , pp. 39-46
    • Pullicino, P.1    Thompson, J.L.2    Barton, B.3    Levin, B.4    Graham, S.5    Freudenberger, R.S.6
  • 90
    • 84929359318 scopus 로고    scopus 로고
    • Risk of stroke in chronic heart failure patients without atrial fibrillation: Analysis of the controlled rosuvastatin in multinational trial heart failure (CORONA) and the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca- Heart Failure (GISSI-HF) trials
    • Wikstrand J, Kjekshus J, Lip GY, Maggioni AP, Tavazzi L, Lees KR, McMurray JJ. Risk of stroke in chronic heart failure patients without atrial fibrillation: Analysis of the controlled rosuvastatin in multinational trial heart failure (CORONA) and the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca- Heart Failure (GISSI-HF) trials. Circulation 2015;131: 1486-1494.
    • (2015) Circulation , vol.131 , pp. 1486-1494
    • Wikstrand, J.1    Kjekshus, J.2    Lip, G.Y.3    Maggioni, A.P.4    Tavazzi, L.5    Lees, K.R.6    McMurray, J.J.7
  • 92
    • 84938555022 scopus 로고    scopus 로고
    • Thromboembolic risk stratification of patients hospitalized with heart failure in sinus rhythm: A nationwide cohort study
    • Wolsk E, Lamberts M, Hansen ML, Blanche P, Kober L, Torp-Pedersen C. Thromboembolic risk stratification of patients hospitalized with heart failure in sinus rhythm: A nationwide cohort study. Eur J Heart Fail 2015;17: 828-836.
    • (2015) Eur J Heart Fail , vol.17 , pp. 828-836
    • Wolsk, E.1    Lamberts, M.2    Hansen, M.L.3    Blanche, P.4    Kober, L.5    Torp-Pedersen, C.6
  • 94
    • 84871254284 scopus 로고    scopus 로고
    • Updated meta-analysis on antithrombotic therapy in patients with heart failure and sinus rhythm
    • Hopper I, Skiba M, Krum H. Updated meta-analysis on antithrombotic therapy in patients with heart failure and sinus rhythm. Eur J Heart Fail 2013;15: 69-78.
    • (2013) Eur J Heart Fail , vol.15 , pp. 69-78
    • Hopper, I.1    Skiba, M.2    Krum, H.3
  • 98
    • 84892981695 scopus 로고    scopus 로고
    • Antiplatelet and anticoagulant agents in heart failure: Current status and future perspectives
    • Gurbel PA, Tantry US. Antiplatelet and anticoagulant agents in heart failure: Current status and future perspectives. JACC Heart Fail 2014;2: 1-14.
    • (2014) JACC Heart Fail , vol.2 , pp. 1-14
    • Gurbel, P.A.1    Tantry, U.S.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.